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Identity 
Other names: DKFZp781A095, KIAA0287, PW1, 
ZNF904, ZSCAN24 




Figure A. PEG3 DNA located on chromosome 19, starts at 62013257 and ends at 62043906 bp. Figure B. The PEG3 gene contains 7-
10 exons with 5 different transcripts. Figure C. PEG3 promoter and first exon. The transcription start site and direction are indicated with 
an arrow. The horizontal bars are 32 CpG sites. The dark blue box is a CpG island surrounded the first exon (Figure modified from Feng 
et al., 2008). 










Human PEG3 was originally identified as an ortholog 
of murine Peg3 that is the first imprinted gene detected 
in mouse chromosome 7. Human PEG3 is located ~2 
Mb proximal of the 19q telomere, which is rich in 
Krüppel-type ZNF genes (Kim et al., 1997). Bisulfite 
sequencing across PEG3 revealed that all CpG 
dinucleotides examined were differentially methylated 
in human fetal brain, kidney, liver, and pancreas. PEG3 
is monoallelically expressed during fetal development, 
it is a maternal-imprinted gene (Murphy et al., 2001). 
Transcription 
The PEG3 gene contains 7-10 exons with 5 different 
transcripts. 
Pseudogene 
There are no known pseudogenes, but an antisense 
transcript gene (APEG3), which is transcribed in the
opposite direction of PEG3, has been identified from 
human. It is confirmed the presence of APEG3 in total 
RNAs from brain thalamus and testis. The functional 
significance of APEG3 is not known. The paternal 
allele-specific expression of anti-sense Peg3 
(imprinting) was detected in mouse brain, but not in 
human yet (Choo et al., 2002). 
Protein 
Description 
PEG3 is maternal-imprinted and paternally expressed. 
The imprinted status of PEG3 throughout development 
and adult life. PEG3 may be a susceptibility locus for 
cancer and for neurobehavioral deficits (Murphy et al., 
2001). 
Expression 
PEG3 is expressed at higher levels in ovary and 
placenta (Kim et al., 1997; Hiby et al., 2001). It was 
also strongly expressed in the adult brain (Kohda et l., 
2001). 
Localisation 
High levels of PEG3 have localized to the layer of 
villous cytotrophoblast cells in the human placenta, 
PEG3 expression is also detected in the ovary stroma 
(Hiby et al., 2001). 
Function 
PEG3 is an imprinted gene expressed exclusively from 
the paternal allele. The precise function of PEG3 is not 
clear, but recent evidence suggests that it plays an 
important role in the p53/c-myc-mediated apoptosis 
pathway. 
PEG3 is a maternally imprinted tumor suppressor gene 
that is downregulated in gliomas, ovarian cancers, 
breast cancers and other gynecologic cancers (Kohda et 
al., 2001; Dowdy et al., 2005; Feng et al., 2008). 
There are several studies revealed murine Peg3 acts as 
an intermediary between p53 and Bax in a cell death 
pathway activated by DNA damage in primary mouse 
cortical neurons, inhibiting Peg3 activity blocks p53-
induced apoptosis (Johnson et al., 2002). Pw1/Peg3 
interacts with a p53-inducible gene product Siah1a. 
Coexpression of Pw1/Peg3 with Siah1a induces 
apoptosis independently of p53. Inhibiting Pw1/Peg3 
activity blocks p53-induced apoptosis (Relaix et al., 
2000). Since human PEG3 is highly conserved with 
murine Peg3, PEG3 may have same function, Jiang et 
al. (2010) demonstrated that enforced overexpression 
of PEG3 mRNA during zebrafish embryogenesis 
decreased beta-catenin protein expression and inhibited 
Wnt-dependent tail development. Peg3/Pw1 also 
inhibited Wnt signaling in human cells by binding to 
beta-catenin and promoting its degradation via a 
p53/Siah1-dependent, GSK3beta-independent 
proteasomal pathway. Hypermethylation of the PEG3 
promoter in primary human gliomas led to a loss of 
imprinting and decreased PEG3 mRNA expression that 
correlated with increasing tumor grade (Jiang et al., 
2010). 
The transcription factor YY1 can bind to the first intron 
of human PEG3, and specifically to the paternal allele 
of the gene. YY1-binding sites are methylated only on 
the maternal chromosome. YY1-binding region may 
function as a methylation-sensitive insulator that could 
influence the imprinted expression of PEG3 (Kim et al., 
2003). 
Homology 
Human PEG3 is known to have orthologs in mice and 
cow. Human PEG3 gene sequences revealed a high 
level of conservation with Murine Peg3 (83% 
similarity), but one of the two proline-rich repeats is 
absent from the human PEG3 (Kim et al., 1997). 
Mutations 
Note 




A significant decrease in PEG3 expression was more 
commonly observed in glioma cell lines as compared 
with that in primary cultures of astrocytes. Transfection 
of PEG3 cDNA in a glioma cell line resulted in a loss 
of tumorigenicity in nude mice (Kohda et al., 2001). 
The epigenetic silencing of PEG3 expression in glioma 
cell lines depends on aberrant DNA methylation of an 
exonic CpG island. Treatment of glioma cell lines with 
the DNA demethylating agent 5-aza-2'-deoxycytidine  
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reversed the silencing of PEG3 biallelically (Maegawa 
et al., 2001). Re-expression of PEG3 in glioma cells 
suppresses their proliferation. Hypermethylation of the 
PEG3 promoter in primary human gliomas led to a loss
of imprinting and decreased PEG3 mRNA expression 
that correlated with tumor grade (Jiang et al., 2010). 
The lower gene expression was confirmed statistically 
in glioblastoma (Otsuka et al., 2009). 
Endometrial cancer, cervical cancer, 
choriocarcinomas 
Note 
PEG3 is silenced in all endometrial and cervical cancer 
cell lines studied. In contrast, loss of maternal 
imprinting and relatively high PEG3 expression leves 
were detected in all four choriocarcinomas cell lines 
studied (Dowdy et al., 2005). 
Breast cancer, ovarian cancer 
Note 
Five of the eight ovarian cancer cell lines were found to 
be PEG3 negative, the remaining three express low 
levels of PEG3 mRNA (Dowdy et al., 2005). PEG3 
was down-regulated in 75% of ovarian cancers. PEG3 
was hypermethylated in 11 of 42 ovarian cancers 
(26%), and PEG3 expression was down-regulated in 10 
of those 11 cancers. LOH was detected in 5 of 25 
informative cases for PEG3 (20%). Re-expression of 
PEG3 markedly inhibited ovarian cancer growth. PEG3 
expression could be restored by treatment with 5-aza-
2'-deoxycytidine and trichostatin A (Feng et al., 2008). 
Hydatidiform moles 
Note 
PEG3 is not mutated in women with familial recurrent 
hydatidiform moles, there is allele-specific methylation 
of the CpG island and expression from the paternal 
allele in two independent informative pedigrees (Van 
den Veyver et al., 2001). 
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